BriaCell Therapeutics Corp.
Pharmaceutical company · West Vancouver, British Columbia, Canada · Nasdaq: BCTX
BriaCell Therapeutics Corp. is a pharmaceutical company headquartered in West Vancouver, British Columbia, Canada. Its shares trade on Nasdaq under the ticker BCTX. It has reported private securities offerings to the US SEC, most recently $27 million sold in a notice filed in 2021.
BriaCell Therapeutics at a glance
What does BriaCell Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $27.2 million sold (2021).
Frequently asked questions about BriaCell Therapeutics
Where is BriaCell Therapeutics headquartered?
BriaCell Therapeutics Corp. is headquartered in West Vancouver, British Columbia, Canada.
What does BriaCell Therapeutics do?
BriaCell Therapeutics Corp. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is BriaCell Therapeutics a public company?
Yes. BriaCell Therapeutics Corp. trades on Nasdaq under the ticker BCTX.
Similar companies
- Aurinia Pharmaceuticals Inc.Edmonton, Alberta, Canada
- AbCellera Biologics Inc.Vancouver, British Columbia, Canada
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- Satellos Bioscience Inc.Markham, Ontario, Canada
- Edesa Biotech, Inc.Markham, Ontario, Canada
- Eupraxia Pharmaceuticals Inc.Vancouver, British Columbia, Canada
- Lexaria Bioscience Corp.Kelowna, British Columbia, Canada
- InMed Pharmaceuticals Inc.Vancouver, British Columbia, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences